Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Italy / NCT05769699
Recruiting Not applicable

Serum Biomarkers in Parkinson's Disease at Different Stages

NCT05769699 · tracked via the Priya Life Science Italy tracker
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase
Not applicable
Started
2022-02-10
Last updated
2023-03-15

Condition(s) studied

Parkinson Disease

Investigational drug(s) / intervention(s)

blood sample

blood sample: blood sample

Study summary

* Determine clinical characteristics of parkinsonian patients in various stages of disease;
* Measure peripheral neurodegeneration, synaptic, and inflammation biomarkers in a population of parkinsonian patients at various stages of disease.
* Measure vesicular neurodegeneration, synaptic and inflammation biomarkers

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Patients diagnosed with idiopathic PD according to Movement Disorders Society (MDS) criteria; * Age: 18-80 years; * Signature of informed consent to participate in this study Exclusion criteria. * Women pregnant * Inflammatory or autoimmune diseases

Primary outcome measure(s)

  • Determine clinical characteristics of parkinsonian patients in various stages of disease — 3 years
    Determine clinical characteristics of parkinsonian patients in various stages of disease by means of MDS-UPDRS score changes.
  • Determine clinical characteristics of parkinsonian patients in various stages of disease — 3 years
    Determine clinical characteristics of parkinsonian patients in various stages of disease by means of NMS score changes.
  • Determine biooogical characteristics of parkinsonian patients in various stages of disease — 3 years
    dosage of serum IL-1b, IL6, IL-5, IL-4, IL17, TNFa, IFNg, IL10, total-alpha-synuclein, NfL, BDNF (ng/ml for all)

Trial sites (1)

FacilityCityRegionStatus
Flavia Torlizzi Roma Italy Recruiting

More Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials in Italy

Spatial Radiogenomics of Ovarian Cancer Recruiting
Cardiovascular Health in Adult Patients With Cancer Exposed to Cardiotoxic Therapies Recruiting
Echocardiographic Characterization of Cardiac Amyloidosis Recruiting
ECT STUDY High-grade or Initially Invasive Vulva - GinOnc-ECT Study Active, not recruiting
Youth Suicide Risk Factors, Reduction of Suicide Risk Factor in Youth People Recruiting

Other trials for the same condition

Steps Against the Burden of Parkinson's Disease - TelAviv/Bologna Recruiting
Saliva and Extracellular Vesicles for Neurodegenerative Diseases Recruiting
Effectiveness of Cognitive Stimulation Treatment in Patients With Parkinson's Disease Recruiting
Design and Validation of Innovative Strategies Based on Dual-Task Approach Active, not recruiting
Comparison of Different Rehabilitation Protocols in Parkinson's Disease With Postural Instability and Gait Disorders Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05769699 on ClinicalTrials.gov ↗ ← All trials in Italy